| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 36,600 | $229,691 | $6.28 | 10 Dec 2021 | Direct |
| Reneo Pharmaceuticals, Inc. | Chief Financial Officer | Stock option (right to buy) | 100,000 | 10 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | 10 Dec 2021 | 2 | $0 | 4 | Chief Financial Officer | 14 Dec 2021, 15:32 |
| OKUR | Reneo Pharmaceuticals, Inc. | 25 Aug 2021 | 1 | +$37,176 | 4 | Chief Financial Officer | 26 Aug 2021, 17:54 |